Dr Reddys Laboratories (RDY) Short term Debt (2018 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Short term Debt of $630.0 million for Q1 2026, up 41.57% year-over-year from $445.0 million in Q1 2025, and up 41.57% quarter-over-quarter from $445.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Short term Debt (2018 - 2026) Analysis & Trends
Dr Reddys Laboratories' Short term Debt history runs 9 years deep, the most recent figure standing at $630.0 million for Q1 2026.
- In Q1 2026, Short term Debt rose 41.57% year-over-year to $630.0 million; the TTM figure through Mar 2026 stood at $630.0 million (up 41.57% YoY), while the FY2026 annual figure was $630.0 million, up 41.57% from the prior year.
- Short term Debt for Q1 2026 stood at $630.0 million, up from $445.0 million in the prior quarter.
- The five-year high for Short term Debt was $630.0 million in Q1 2026, with the low at $13.0 million in Q1 2022.
- The 5-year median for Short term Debt is $90.0 million (2023), against an average of $238.8 million.
- The sharpest annual moves came in 2024 and 2025: Short term Debt slumped 82.22% in 2024, then jumped 2681.25% in 2025.
- Dr Reddys Laboratories' Short term Debt stood at $13.0 million in 2022, then jumped by 592.31% to $90.0 million in 2023, then plunged by 82.22% to $16.0 million in 2024, then surged by 2681.25% to $445.0 million in 2025, then soared by 41.57% to $630.0 million in 2026.
- Business Quant data shows RDY's Short term Debt at $630.0 million in Q1 2026, $445.0 million in Q1 2025, and $16.0 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.00 Mn |
| Mar 31, 2025 | 445.00 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Mar 31, 2023 | 90.00 Mn |
| Mar 31, 2022 | 13.00 Mn |
| Mar 31, 2021 | 12.00 Mn |
| Mar 31, 2020 | 57.00 Mn |
| Mar 31, 2019 | 62.00 Mn |
| Mar 31, 2018 | 1.00 Mn |